SWS Medical Recognized as a Leader in Global Medical Device Innovation at CMEF 2025
Release time: Apr 11 09:56:05, 2025
Shanghai, China – April 2025 — SWS Hemodialysis Care Co., Ltd., a leader in blood purification technologies since 2001, has been honored in the 2025 Guidelines for the Selection of High-Quality Medical Devices Going Abroad from China. Compiled by the Lingang New Area Medical Device Innovation Center and unveiled at the China Medical Equipment Fair (CMEF),this guide recognizes elite Chinese medical device brands, showcasing their ability to deliver innovative healthcare solutions globally.
Notable companies, including industry giant United Imaging Healthcare and MicroPort, appear alongside SWS Medical, reflecting its status as a national leader in renal care. The announcement at CMEF Spring 2025—Asia’s premier medical industry event with over 120,000 attendees—reinforces SWS's role as a crucial partner in addressing global healthcare challenges, including the rising burden of renal diseases and critical care shortages, thereby solidifying its influence in international medical supply chains.
In Q1 2025, SWS once again achieved the top market share in China for both hemodialysis and CRRT machines, maintaining its position as the leading exporter of blood purification equipment. This achievement driven by a vertically integrated ecosystem that ensures rigorous compliance with international standards, underscores SWS’s commitment to excellence.
As the first blood purification company listed on Shanghai’s STAR Market (SSE: 688410), SWS has driven industry innovation through 12 national standards and 177 patents (including 2 international patents), with its technologies benefitting patients in over 80 countries. The bilingual Guidelines, supported by government and industry endorsements, serve as a strategic roadmap for international buyers seeking clinically validated Chinese innovations, illustrating SWS’s adaptability across diverse healthcare landscapes, from emerging markets to stringent regulatory environments like the EU.
By taking a proactive role in global markets, SWS is not only driving its own success but also enhancing the reputation of Chinese medical device companies on the world stage.
About SWS Hemodialysis Care Co., Ltd.
Based in Chongqing, SWS Medical is a prominent global provider of innovative medical products and services. Its offerings include advanced blood purification devices, high-quality disposables, intelligent dialysis management system, and a network of dialysis centers. SWS is uniquely positioned with a comprehensive blood purification industrial chain, chairs the China Blood Purification Industry Technology Innovation Strategic Alliance, and leads the development of national and industry standards. Publicly traded on the STAR Market (SSE: 688410), its devices hold CE markings and comply with ISO 13485:2016 standards.